[The low expression of long non-coding RNA Linc00638 contributes to rheumatoid arthritis progression by regulating inflammation and oxidative stress].

OBJECTIVE To investigate the expression of long non-coding RNA (lncRNA) Linc00638 in rheumatoid arthritis (RA) and its regulatory role in inflammation and oxidative stress of synovial fibroblasts in RA patients (RA-FLS). METHODS Peripheral blood mononuclear cells (PBMCs) were collected from 20 healthy individuals and 35 RA patients for detecting the expression of Linc00638 using RT-qPCR to analyze the correlation of Linc00638 expression with the clinical indicators of RA patients. A Linc00638 overexpression plasmid and siRNA targeting Linc00638 were transfected into RA-FLS, and the changes in cell viability was observed using CCK8 assay; the changes in the expression levels of interleukin-4 (IL-4), IL-6, reactive oxygen species (ROS) and superoxide dismutase (SOD) in the supernatant were detected using ELISA. RESULTS Compared with the healthy control subjects, RA patients had significantly increased ESR, CRP, RF, anti-CCP, IgA, and C4 levels (P < 0.05) and significantly decreased Linc00638 expression in the PBMCs (P < 0.01). The area under the receiver-operating characteristic (ROC) curve of Linc00638 was 91.86% with the best cut-off value of 0.74 for diagnosis of RA. Spearman correlation analysis showed that Linc00638 expression level was negatively correlated with age, course of disease, DAS28, ESR, CRP, RF and anti-CCP, and positively correlated with IL-4 and SOD levels (P < 0.05). Association rule analysis showed that a decreased Linc00638 expression was strongly correlated with an increase of age (>60 years), a longer disease course (>10 years), elevated levels of ESR, RF and anti-CCP, and decreased levels of IL-4 and SOD. In RA-FLS, overexpression of Linc00638 significantly inhibited while Linc00638 interference obviously enhanced the cell viability. Over-expression of Linc00638 also significantly increased the levels of IL-4 and SOD (P < 0.05) and decreased the expressions of IL-6 and ROS (P < 0.05), while interference of Linc00638 produced the opposite effects in the cells (P < 0.05). CONCLUSION RA patients have low expression levels of Linc00638, which may participate in disease progression by regulating inflammation and oxidative stress.

[1]  A. Kızıltunç,et al.  Evaluation of oxidant and intracellular anti-oxidant activity in rheumatoid arthritis patients: In vivo and in silico studies. , 2021, International immunopharmacology.

[2]  Hyo Jin Kim,et al.  Sargassum horneri ethanol extract containing polyphenols attenuates PM-induced oxidative stress via ROS scavenging and transition metal chelation , 2021 .

[3]  K. P. Devi,et al.  Dihydroactinidiolide regulates Nrf2/HO-1 expression and inhibits caspase-3/Bax pathway to protect SH-SY5Y human neuroblastoma cells from oxidative stress induced neuronal apoptosis. , 2021, Neurotoxicology.

[4]  Yao Huang,et al.  Si Miao San Attenuates Inflammation and Oxidative Stress in Rats with CIA via the Modulation of the Nrf2/ARE/PTEN Pathway , 2021, Evidence-based complementary and alternative medicine : eCAM.

[5]  T. Arayssi,et al.  Perceptions of patients with rheumatoid arthritis about self-assessment of disease activity after watching an educational video: a qualitative pilot study from the AUTO-DAS in Middle Eastern Arab countries project , 2021, Rheumatology International.

[6]  Wei Zhu,et al.  LncRNA H19 regulates macrophage polarization and promotes Freund's complete adjuvant-induced arthritis by upregulating KDM6A. , 2021, International immunopharmacology.

[7]  N. Žarković,et al.  Oxidative Stress and Lipid Mediators Modulate Immune Cell Functions in Autoimmune Diseases , 2021, International journal of molecular sciences.

[8]  T. Melo,et al.  Insights in the Role of Lipids, Oxidative Stress and Inflammation in Rheumatoid Arthritis Unveiled by New Trends in Lipidomic Investigations , 2021, Antioxidants.

[9]  F. Iordache,et al.  Oxidative stress mitigation by antioxidants - An overview on their chemistry and influences on health status. , 2020, European journal of medicinal chemistry.

[10]  L. Wan,et al.  Prediction of Self-Perception of Patient in Rheumatoid Arthritis With the Key RNAs Expression Profiles , 2020, Frontiers in Medicine.

[11]  C. Buckley,et al.  Nurse-led care for the management of rheumatoid arthritis: a review of the global literature and proposed strategies for implementation in Africa and the Middle East , 2020, Rheumatology International.

[12]  Sen Chen,et al.  LncRNA LOC100912373 modulates PDK1 expression by sponging miR-17-5p to promote the proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. , 2020, American journal of translational research.

[13]  Yue-Hui Zhang,et al.  Systematic identification of lncRNAs and circRNAs-associated ceRNA networks in human lumbar disc degeneration , 2019, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[14]  G. Valesini,et al.  The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis , 2018, Front. Immunol..

[15]  J. Zwerina,et al.  How antirheumatic drugs protect joints from damage in rheumatoid arthritis. , 2008, Arthritis and rheumatism.